- Journalists Highlight Medical Neglect in ICE Detention, RFK Jr. Antidepressant Comments
- 18 new behavioral health study findings to know
- How 5 systems are embedding behavioral health into clinical care
- ‘Who watches the watchmen?’ CMS tightens oversight of accrediting bodies — 8 things to know
- 8 hospital projects worth $1B+ in 2026
- UnitedHealth, FTC near insulin rebates settlement
- The hidden disparity built into healthcare interoperability
- Christus consolidates inpatient services at Texas hospital
- Health AI regulation gaps span scribes, prior authorization: 5 notes
- Is cardiac catheterization the new cataract surgery?
- CMS floats permanent status for Medicare drug price negotiations: 5 things to know
- 13 cybersecurity updates for ASC leaders to know
- The safety issue hiding in ASC staffing
- Elevance sues former chief execution officer over noncompete agreement
- 15% of pregnant women report current alcohol use: CDC
- 15% of pregnant women report current alcohol use: CDC
- California healthcare district board member resigns to apply for CEO role
- Vermont regulators greenlight new ASC
- What surgeons don’t understand about anesthesia
- National Real Estate Advisors acquires Montana medical campus with ASC, MOB
- 5 ASC, ambulatory leaders from the biggest health systems
- Ohio dentist to retire after 34 years, close practice
- Good news, bad news for DSOs
- California Health Worker Union, Hospital Association Tout Dueling Ballot Initiatives
- Nearly 13,000 dental professionals needed to fill shortage areas: HRSA
- The states with the widest anesthesiologist salary spreads
- Optum Rx, FTC posed for settlement in insulin pricing case
- 7 new behavioral health projects representing nearly $1B in investment
- How the fastest-growing DSO is expanding its network
- Program closures, practice openings & more: 5 oral surgery updates 30 days
- CMS proposes permanent framework for Medicare drug price negotiations
- CMS proposes permanent framework for Medicare drug price negotiations
- Dental hygienist pay up 21% since 2021
- ‘Making a bad situation worse’: 15% of psych beds lost in 4 California counties after staffing rule
- How dentist pay has evolved over the last 5 years
- Nearly 30% of Massachusetts residents filled behavioral health prescriptions
- Rhode Island Senate advances bill creating licensure pathway for foreign-trained dentists, hygienists
- The 10 states where physician assistant pay jumped the most
- Anesthesia stipends by the numbers
- SAMHSA unveils $40M behavioral health grant funding: 5 things to know
- Best, worst states for child well-being
- 5 dental school updates to know
- 7 DSOs making headlines
- Influencers, Booze And Teens: What's Showing Up In Their Feeds?
- Health 'War Room,' Digital Tools Are Tracking Disease Risks During World Cup
- Mercer survey: Employers eye cost-shifting strategies as health benefit spend rises
- Nvidia, Abridge collaborate to develop healthcare-specific AI model
- EHA: J&J sharpens myeloma edge as Talvey, Darzalex Faspro combo proves its worth in earlier disease stage
- Industry Voices—Why health systems need physicians engaged in IT leadership
- FDA hearing on Amgen's Tavneos will include findings from an independent review
- In latest twist in Zepzelca saga, Jazz and PharmaMar lung cancer drug fails phase 3 test
- Food Labels and Restrictions Can Lower Childhood Obesity Rates, Study Finds
- Tourette Patients Face High Suicide Risk, Pain And Discrimination
- Have A Risk-Taking Teen? This Brain Chemical Might Be Responsible, Researchers Say
- Sepsis, Lung Infection Patients See No Benefit From Remote Monitoring
- Overlooked Social Connections Can Prevent Suicide
- Final Rules for Medicaid Work Requirements Are Out. Here’s What You Need To Know.
- 1 in 4 Covered California Enrollees Could Get State Aid Under Newsom Proposal
- Lilly, Biogen, Eisai and Genentech sponsor new ‘Let’s Talk Alzheimer’s’ podcast
- Fierce Pharma Asia—Astellas CEO’s 5-year plan; Takeda’s psoriasis win; RA’s China bridge program
- Why this behavioral health provider just bought a pharmacy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- North Carolina awards $10M to expand rural behavioral healthcare access
- Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
- Provider groups file lawsuit against HHS over anti-trans Ryan White funding rules
- Genentech executes another round of layoffs, with 3 VPs axed
- Humana to sell off minority stake in end-of-life care provider Gentiva
- Vitamin C May Be Key To A Healthier Brain As You Age
- New Vaccine Schedule Released By American College of Obstetricians & Gynecologists
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- AI use is surging across HHS, jumping 148% at the FDA in 2025, Bipartisan Policy Center data finds
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Novo reports data breach, tells clinical trial patients to 'remain vigilant'
- ‘Not simply saving cost’: Inside Astellas CEO’s 5-year strategy to counter Xtandi’s patent cliff
- OIG: Frequent MA prior authorization denials for long-term care hospitals, inpatient rehab
- From Medicaid work requirement exemptions to AI safeguards in coverage: New AMA policies from annual meeting
- Joint initiative of 5 EU countries calls for 'unified approach' to pharma framework amid US drug pricing pressure
- J&J eyes rare disease expansion for blockbuster-to-be Imaavy with trial win
- Virtual care tech companies launch 'out-of-the-box' RPM tool for pharmacies
- Can Fasting Treat Gum Disease? Study Finds Reduced Inflammation
- Living With Cats Not Linked To Worse Asthma in Children
- Few Stroke, Brain Injury Survivors Get Top-Quality Hospital Rehab
- Popular Joint Pain Supplement, Glucosamine, Might Increase Alzheimer's Risk, Study Says
- Anguished Parents. Doctors In Tears. Utah's Long Measles Outbreak Takes A Toll.
- Madrigal takes giant inflatable liver on US tour in disease awareness push
- Listen to the Latest ‘KFF Health News Minute’
- Trump Bought Tobacco Stocks and Raked In Industry Donations as FDA Eased Standards
- Olixir NY teams with Crohn's & Colitis Foundation for ‘Spill Your Guts’ campaign
- Takeda’s TYK2 inhibitor beats Bristol Myers’ Sotyktu in phase 3 psoriasis showdown
- Hospital associations push CMS for higher 2027 pay bump, softer ramp-up for mandatory model
- AHIP 2026: Why Ascendiun CEO Paul Markovich is bullish on building out a digital health record for patients
- FDA’s Greenlight of Old Chemical Offers Chance To Restore Faith in Sunscreen
- Abridge picks up strategic investment from Eli Lilly, expands payer, research workflows
- Weekly Rundown: Karias Health launches AI companion; Mount Sinai, Wisp partner to expand PrEP access in NY
- Sugary Beverages May Raise Your Risk of Liver Cancer
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Ardent Health's surprise CEO change reflected need for margin focus amid headwinds, CFO says
- FDA Approves First New Sunscreen Ingredient, Bemotrizinol, in Two Decades
- Trustees expect Medicare Trust Fund's reserves to run out in 2033
- Vega Health licenses AI models from Parkland Center for Clinical Innovation to predict patient risks
- Eli Lilly yells ‘action’ on authentic patient portrayals at Tribeca Festival
- Teen Recovering From Concussion? A 'Sweet Spot' For Screen Time Could Speed Up Their Recovery
- AMA issues policy urging exemptions in upcoming Medicaid work requirements
- Pfizer CEO Bourla reconsiders German investments as industry takes aim at healthcare reform plan: Reuters
- Big Pharma-backed SonoThera sounds off with $125M series B for bubble-based genetic delivery
- Teva to lay off 250 at API unit as search for new owner drags on: report
- Women Hit Harder By Sleep Apnea Than Men, Study Finds
- Retro Video Game Aids Stroke Recovery, Improves Arm Function
- Experimental, Once-Daily GLP-1 Pill, Elecoglipron, May Offer New Option for Weight Loss, Diabetes
- Anguished Parents. Doctors in Tears. Utah’s Long Measles Outbreak Takes a Toll.
- Looming Medicaid Cuts Supercharge California’s Latest Labor-Industry Fight
- Genentech and Novartis dish up food allergy microdrama series
- ‘I’m a lot more optimistic today’: Mike Doustdar tells Fierce about pivotal first year as Novo Nordisk CEO
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- How Much Alcohol Is Actually Safe? A New Study Challenges Old Advice
- AbbVie’s Skyrizi narrowly slides ahead of J&J’s Tremfya in May drug ad spending rankings
- Air Pollution Might Contribute To Clogged Arteries, Heart Disease Risk
- New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
- Feeding Babies Eggs Sooner May Cut Allergy Risk, Study Suggests
- At A Tennessee Hospital, Nurse Stole Fentanyl And AI Missed It, State Records Say
- Infections A ‘Major Health Hazard’ For People With Diabetes, Large Study Warns
- MAHA's Treatments For Autism: Camel's Milk, Stem Cell Injections — And Spelling Therapy
- Trivia Nights, Valentine’s Cards: Overlooked Social Connections Can Prevent Suicide
- AI medical advice changes care decisions of most users: survey
- FDA Expands Sunscreen Options for the First Time in 20 Years
- Children's Well-Being Plummets Across 29 States, Report Finds
- Just 5 Minutes Of Prayer Helps Reduce Pain and Anxiety, Study Finds
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- Irregular Sleep Risks Preschool Kids' Brain Power
- Why Alcohol Makes You Crave Salty Snacks — And How Protein-Rich Foods Can Help Prevent Weight Gain
- ADHD ‘Masking’ May Help People Blend In But Harms Mental Health
- Getting The RSV Shot, Abrysvo, While Pregnant Could Protect Your Baby After Birth
- Upcoming Billing Change Could Make Pregnancy Pricier
- Dengue Is No Longer Just A Travel Risk — What Google’s Mosquito Plan Could Mean For Your Summer
- Brain Surgery For Pituitary Tumor Helps Illinois Mom Have Second Baby
- Popular Blood Pressure Meds, Dihydropyridine Calcium-Channel Blockers, Linked To Kidney Damage Risk In Type 2 Diabetes
- Too Much Sitting In Pregnancy Doubles Risk Of Complications
- Spinal Cord Stimulation May Restore Arm Strength After Stroke
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks at the Investor Advisory Committee Meeting
- Base Case: Remarks at the IC3 Blockchain Camp
- Commission Statement on the Passing of Former General Counsel David Becker
- MedTech In Focus: AI impact in healthcare
- If Your AI Can’t Explain Itself, Can FDA Authorize It?
Michigan healthcare freedom community forum
Brownstein Hyatt Farber Schreck (Wikipedia)
Their summary of the proposed federal budget is the best I found on a quick internet search. Please feel free to add others, especially more recent information.
I'll follow with an article on the importance of health policy in this election.
Biden Reveals Health Care Priorities in FY 2025 Budget
BROWNSTEIN CLIENT ALERT, MARCH 11, 2024
<clip>
A more detailed breakdown of the Department of Health and Human Services’ (HHS) budget request can be found here. The FY 2025 budget contains numerous health initiatives and priorities including:
- Reduces Drug and Other Health Care Costs for All Americans.
- Expands the IRA’s inflation rebates and $2,000 out-of-pocket prescription drug cost cap beyond Medicare and into the commercial market.
- Extends the $35 cost-sharing cap for a month’s supply of covered insulin products to the commercial market.
- Limits Medicare Part D cost-sharing for high-value generic drugs to no more than $2 for Medicare beneficiaries.
- Increases the pace of drug price negotiations by bringing more drugs into negotiation sooner after they launch.
- Authorizes HHS to negotiate supplemental drug rebates on behalf of interested states to pool purchasing power.
- Makes permanent the expanded Affordable Care Act (ACA) premium tax credits that were extended in the IRA.
- Provides Medicaid-like coverage to individuals in states that have not adopted Medicaid expansion, paired with financial incentives to ensure states maintain their existing expansions.
- Allows banning “facility fees” for telehealth and certain outpatient services in commercial insurance.
- Funds the continued implementation of the No Surprises Act.
- Honors America’s Commitment to Seniors and Americans in Need.
- Extends solvency of the Medicare Hospital Insurance (HI) trust fund indefinitely by ensuring high-income individuals pay their fair share.
- Proposes limiting the portion of Medicaid and CHIP managed care dollars spent on administration and incentivizing more investment in health care services by establishing a medical loss ratio.
- $150 billion over 10 years to improve and expand Medicaid home and community-based services (HCBS).
- Shifts funding for nursing home surveys from discretionary to mandatory beginning in 2026 and increases funding to cover 100% of statutorily mandated surveys.
- Proposes requiring greater transparency of nursing facility ownership and increasing the inspection of facilities with serious safety deficiencies.
- Invests in the Health and Well-Being of Families and the Next Generation.
- $390 million, a 36% increase above the 2023 enacted level, for the Title X Family Planning program to increase the number of patients served to 3.6 million.
- Transforms Behavioral Health Care.
- $1 billion to advance health information technology adoption and engagement in interoperability for certain behavioral health providers.
- Increases funding for the Children’s Mental Health Initiative by $50 million.
- Expands access to behavioral health services through investments in Certified Community Behavioral Health Clinics and Community Mental Health Centers.
- Doubles funding for the Mental Health Crisis Partnership Program.
- Invests in strengthening the behavioral health workforce, including integration into primary care settings.
- Proposes to extend incentive payment programs for Medicare providers in areas with clinician shortages to a broader set of clinicians, including behavioral health clinicians.
- Expands coverage of mental health benefits and strengthens the network of behavioral health providers in commercial insurance.
- Increases funding for the State Opioid Response grant program.
- Invests in a new technical assistance center to strengthen health providers’ understanding and treatment of substance use and women’s mental health.
- Invests in Medical Innovation, Scientific Breakthroughs and the Treatments of Tomorrow.
- $2 billion increase across the National Cancer Institute, Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and cancer projects at the Advanced Research Projects Agency for Health (ARPA-H).
- Additional mandatory funds for the Indian Health Service (IHS) beginning in 2026.
- Proposes creating a nationwide network of centers of excellence and innovation in women’s health.
- Doubles existing funding for the Office of Research on Women’s Health at the National Institutes of Health (NIH).
- Advances Health Equity.
- $376 million, an increase of $82 million above the 2023 enacted level, to support the ongoing implementation of the White House Blueprint for Addressing the Maternal Health Crisis.
- Expands Medicaid maternal health support services during the pregnancy and postpartum period by incentivizing states to reimburse a broad range of providers, including doulas, community health workers, peer support initiatives and nurse home visiting programs.
- $8 billion in discretionary resources in 2025, a 12% increase over the 2021 enacted level, for clinical services, preventative health, facilities construction, contract support costs and tribal leases at IHS.
- Proposes all IHS resources as mandatory beginning in 2026.
- Reauthorizes and increases funding for the Special Diabetes Program for Indians.
- Invests in direct primary care and mental health care services, expanded infrastructure and assistance for rural hospitals to remain open and provide high-quality services.
- Protects and Strengthens Public Health and Health Infrastructure.
- $2.5 billion in discretionary and mandatory funds over 10 years at CDC to support an evidence-based community violence initiative to address the causes of violence in communities and help reduce health inequities that characterize violence.
- $60 million for gun violence research across CDC and NIH.
- $9.8 billion in discretionary and mandatory funding for the Prevention and Public Health Fund, an increase of $499 million over the 2023 enacted level.
- $20 billion in mandatory funding for HHS public health agencies in support of the administration’s biodefense priorities as outlined in the 2022 National Biodefense Strategy and Implementation Plan for Countering Biological Threats, Enhancing Pandemic Preparedness, and Achieving Global Health Security.
- $75 million in the Administration for Strategic Preparedness and Response (ASPR) to manufacture more essential medicines, medical countermeasures and critical inputs in the United States.
- $12 million to strengthen FDA’s capacity to identify and address potential disruptions and shortage threats.
- Expands end-to-end supply chain visibility to priority FDA-designated essential medicines and devices to prepare for and mitigate potential shortages.
- Creates a new office to coordinate agency-wide activities on supply chain resilience and shortage mitigation efforts for drugs, biologics, medical devices and critical foods.
- Proposes a national program to significantly expand screening, testing, treatment, prevention and monitoring of hepatitis C infections in the United States.
- Proposes a new mandatory program to guarantee PrEP at no cost for all uninsured and underinsured individuals.
- Proposes a new Vaccines for Adults program to provide uninsured adults with access to routine and outbreak vaccines at no cost.
- Invests in protecting the health care system from cyber threats and includes funding for ASPR to coordinate cybersecurity efforts.
- $800 million to help high-need, low-resourced hospitals cover the upfront costs associated with implementing essential cybersecurity practices.
- $500 million for an incentive program to encourage all hospitals to invest in advanced cybersecurity practices.
- $141 million to continue strengthening HHS’s ability to protect and defend HHS systems and information, including $11 million to expand and enhance HHS’ capacity to protect the privacy and security of health information.
- Invests in HHS’ role in promoting the use of artificial intelligence (AI) in health care and public health while protecting against its risks.
As mentioned above, the president’s budget request starts the congressional budget and appropriations process. The budget presented by the Biden administration provides an aspirational roadmap to what the president would like to be implemented and how much Congress integrates these ideas into their own remains to be seen.
Followers of the MHF Forum and Michigan health policy will recognize many of these funds already leveraging policy in our state.
Joe Grogan has penned an avowedly partisan recapitulation of the ways Medicare funding has been looted to finance non medical programs in recent years:
The Honest Truth About Health Policy
As a frail President Biden walks onto the debate stage this week with the considerable challenge of defending a disastrous record on foreign policy, inflation, and border policies, he is certain to try to use healthcare as an area to score points against President Trump. The campaign is already airing ads on the subject. The media largely ignored or misrepresented Trump’s record on healthcare but there is one area that probably can’t be ignored any longer: Biden’s Medicare policies are hitting seniors hard.As he works to boost support from seniors, Biden has attempted to paint Trump as a threat to Medicare, but the truth is that Biden and the Democrats raided Medicare for green energy subsidies and America’s seniors are paying the price. In 2022, Democrats rammed through the Inflation Reduction Act (IRA) with major changes to Medicare’s prescription drug reimbursement—previously an area of bipartisanship—without a single Republican vote.
President Trump by contrast quietly pursued bipartisan changes, engaging with Senators Grassley and Wyden, Majority Leader McConnell and Speaker Pelosi for negotiations on a bipartisan drug pricing bill to help seniors manage drug costs and preserve the program, but that construct was tossed aside when Democrats took both legislative chambers and the White House and had the chance to implement drug price controls.
Much has been written about how Biden’s drug price setting scheme has led numerous developers to cancel research programs, and more cancellations are around the corner. But what has not gotten enough attention is that in a real feat of policy incompetence, cost savings for seniors are still years away, but seniors are already paying more for drug coverage. Plans requested an average premium increase of 21.5% for 2024 and requests will likely be elevated for 2025 as well. While Democrats included a cap on one factor used to determine beneficiary premiums, the cap does not extend to the premium as a whole. This, coupled with poorly designed changes to Medicare Part D’s structure triggered astronomical premium increases.
Part D instability will grow in 2025 and 2026 as the program’s price fixing provisions kick in and the rebates that keep premiums down disappear. Premiums will need to go up or benefit generosity will need to go down. Some plans may simply stop offering coverage in certain areas next year.
Why would Democrats destabilize the program and impose higher costs on seniors? A generous explanation might be that they didn’t think that this many drug development programs would get cancelled and they didn’t understand that the changes they were making to Part D’s structure would be catastrophic. But a more ideological explanation, and I think a more accurate one, is that Democrats just got greedy, which is ironic since this is their standard attack line against drug companies.
When President Trump proposed restructuring Part D to help seniors, all of the savings in drugs costs accrued to seniors and stayed in the Medicare program. But Democrats needed to loot Part D to pay for the green energy subsidies of the IRA.
Put another way, Biden cut benefits from people with a median income of $36,000 per year to subsidize cars purchased by individuals who earn five times as much. This $240 billion raid on Medicare would be shocking if they hadn’t done it before; Democrats cut $450 billion to $716 billion from Medicare to fund the Affordable Care Act.
When Republicans had both legislative houses and the White House under President Trump, we cut taxes. When Democrats had both houses under Obama and Biden, they raided Medicare to create new programs.
So, when Biden says Medicare won’t be cut on his watch, people should know he already did. Under Donald Trump; benefits were made more generous, particularly for Medicare Advantage enrollees, who Trump allowed to better manage their chronic conditions with enhanced benefits, such as home modifications to address disability. Ironically, the Biden Administration has spent the last three years squeezing Medicare Advantage and costing seniors more money. All the while, they have demonized for-profit companies in health care as they waged war against them.
For the first time in history Thursday night’s debate will feature two candidates who have both held the office defending their records, attacking the other’s. Biden’s team is hoping healthcare might provide a rare window to go on offense, but their actions while in office betray them. And by any objective measure, Trump’s record protecting Medicare is far better than the Biden record of looting it.
During the ACA/Obamacare debates, "Healthcare is 1/6 of the economy" became common knowledge.
Yes. They are connected.
In this timely debate prep, NBC refreshes our frame of reference.
Health care just as important as economy. What experts want Biden and Trump to address.
About half of U.S. adults say it is difficult to pay for their medical care. June 26, 2024, 11:03 AM EDTWhen President Joe Biden and former President Donald Trump face off Thursday during the first general election debate, health policy experts say tackling the exorbitant cost of health care is as much a top issue for voters as the U.S. economy.
Health care costs in the United States continue to rise — and Americans increasingly say they are unable to afford the care they need.
There is no issue in health care even remotely close to voter frustration over the high prices patients have to pay for medical care, said Drew Altman, president and CEO of KFF, a nonprofit group that researches health policy issues.
“People tend to think about health care as separate from the economy,” he said. “But when you talk to voters, it’s not separate at all in their heads. Health care is a dimension of their pocketbook economic concerns.”
National health care spending is projected to have increased 7.5% in 2023 to almost $4.8 trillion, faster than the projected growth of the overall economy, according to the Centers for Medicare and Medicaid Services.
The estimated health care spending per person — the average amount spent on health care services for each individual — reached $14,423 in 2023, up from $13,493 in 2022 and $13,012 in 2021.
The rising cost is hitting Americans’ wallets. About half of U.S. adults say it is difficult to afford their health care costs, according to a recent poll from KFF. About 1 in 4 say they — or a family member — had problems paying for health care in the past year.
That often means people will have to skip or delay the care that they need, said Dr. Adam Gaffney, a critical care physician at the Cambridge Health Alliance, who was not involved in the polling. A family member may try to provide financial aid, he added, but attempts to help another can sometimes aggravate problems for the entire family — most notably with medical debt.
"For American households, health care costs are one of the most important economic issues," he said. “What we spend on health care is going to be one of the biggest line items for a lot of families, particularly families with children or with elderly people with chronic diseases.”
No sweeping reform
Although Trump has revived threats to dismantle the Affordable Care Act, also known as Obamacare, major health care reform is unlikely to be a central issue during the debate, Altman said.
Biden is likely to tout the Inflation Reduction Act, which he signed into law in 2022.
Among the provisions is allowing Medicare, for the first time, to directly negotiate drug prices with pharmaceutical companies. Earlier this year, the government began negotiating prices on the 10 costliest prescription drugs covered by Medicare, which included heart medications and diabetes drugs. The government is expected to publish the new negotiated prices by Sept. 1.
Aside from Obamacare and abortion, Trump has provided little detail on what health care policy would look like in a potential second term. He made addressing the high cost of prescription drugs a tentpole of his previous term, including a push to allow states to import drugs from Canada and a rule that would tie prices for certain drugs to prices paid by countries overseas.
The greatest challenge for both Biden and Trump will be pitching health care cost policies that both sides of Congress can get behind, said Robin Feldman, a professor of law and director of the Center for Innovation at UC Law San Francisco.
“Notions of unity and compromise seem to be a distant memory in Congress, as they are in the nation,” she said.
”The idea of a big major sweeping reform has felt unlikely in recent years,” Gaffney said.
Breakthrough reforms remain challenging — but important.
“This distinction between health care as an issue and the economy as an issue at this point drives me crazy, because for real people, there is no distinction,” Altman said. “It’s one of their biggest economic concerns.”
Berkeley Lovelace Jr. is a health and medical reporter for NBC News. He covers the Food and Drug Administration, with a special focus on Covid vaccines, prescription drug pricing and health care. He previously covered the biotech and pharmaceutical industry with CNBC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.





















